These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 12867538

  • 1. The PON1 M55L gene polymorphism is associated with reduced HDL-associated PAF-AH activity.
    Kakafika AI, Xenofontos S, Tsimihodimos V, Tambaki AP, Lourida ES, Kalaitzidis R, Cariolou MA, Elisaf M, Tselepis AD.
    J Lipid Res; 2003 Oct; 44(10):1919-26. PubMed ID: 12867538
    [Abstract] [Full Text] [Related]

  • 2. Fenofibrate induces HDL-associated PAF-AH but attenuates enzyme activity associated with apoB-containing lipoproteins.
    Tsimihodimos V, Kakafika A, Tambaki AP, Bairaktari E, Chapman MJ, Elisaf M, Tselepis AD.
    J Lipid Res; 2003 May; 44(5):927-34. PubMed ID: 12611907
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB.
    Tsimihodimos V, Karabina SA, Tambaki AP, Bairaktari E, Goudevenos JA, Chapman MJ, Elisaf M, Tselepis AD.
    Arterioscler Thromb Vasc Biol; 2002 Feb 01; 22(2):306-11. PubMed ID: 11834533
    [Abstract] [Full Text] [Related]

  • 5. Thyroid substitution therapy induces high-density lipoprotein-associated platelet-activating factor-acetylhydrolase in patients with subclinical hypothyroidism: a potential antiatherogenic effect.
    Milionis HJ, Tambaki AP, Kanioglou CN, Elisaf MS, Tselepis AD, Tsatsoulis A.
    Thyroid; 2005 May 01; 15(5):455-60. PubMed ID: 15929667
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Lack of association between carotid intima-media thickness and PAF-acetylhydrolase mass and activity in patients with primary hyperlipidemia.
    Kiortsis DN, Tsouli S, Lourida ES, Xydis V, Argyropoulou MI, Elisaf M, Tselepis AD.
    Angiology; 2005 May 01; 56(4):451-8. PubMed ID: 16079929
    [Abstract] [Full Text] [Related]

  • 9. Higher Levels of Oxidized Low Density Lipoproteins in Alzheimer's Disease Patients: Roles for Platelet Activating Factor Acetyl Hydrolase and Paraoxonase-1.
    Bacchetti T, Vignini A, Giulietti A, Nanetti L, Provinciali L, Luzzi S, Mazzanti L, Ferretti G.
    J Alzheimers Dis; 2015 May 01; 46(1):179-86. PubMed ID: 25720407
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Studies on HDL associated enzymes under experimental hypercholesterolemia: possible modulation on selenium supplementation.
    Kaur HD, Bansal MP.
    Lipids Health Dis; 2009 Dec 16; 8():55. PubMed ID: 20015371
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Altered distribution of platelet-activating factor- acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia.
    Tsimihodimos V, Karabina SA, Tambaki AP, Bairaktari E, Miltiadous G, Goudevenos JA, Cariolou MA, Chapman MJ, Tselepis AD, Elisaf M.
    J Lipid Res; 2002 Feb 16; 43(2):256-63. PubMed ID: 11861667
    [Abstract] [Full Text] [Related]

  • 15. Effects of antihypertensive and hypolipidemic drugs on plasma and high-density lipoprotein-associated platelet activating factor-acetylhydrolase activity.
    Tambaki AP, Rizos E, Tsimihodimos V, Tselepis AD, Elisaf M.
    J Cardiovasc Pharmacol Ther; 2004 Jun 16; 9(2):91-5. PubMed ID: 15309245
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Platelet activating factor-acetylhydrolase (PAF-AH) activity and HDL levels, but not PAF-AH gene polymorphisms, are associated with successful aging in Sicilian octogenarians.
    Campo S, Sardo MA, Trimarchi G, Bonaiuto A, Saitta C, Bitto A, Castaldo M, Cinquegrani M, Bonaiuto M, Cristadoro S, Saitta A.
    Aging Clin Exp Res; 2008 Apr 16; 20(2):171-7. PubMed ID: 18431085
    [Abstract] [Full Text] [Related]

  • 19. Study of the paraoxonase and platelet-activating factor acetylhydrolase activities with aging.
    Milochevitch C, Khalil A.
    Prostaglandins Leukot Essent Fatty Acids; 2001 Apr 16; 65(5-6):241-6. PubMed ID: 11993715
    [Abstract] [Full Text] [Related]

  • 20. Effect of paraoxonase 1 polymorphisms on the response of lipids and lipoprotein-associated enzymes to treatment with fluvastatin.
    Christidis DS, Liberopoulos EN, Kakafika AI, Miltiadous GA, Liamis GL, Kakaidi B, Tselepis AD, Cariolou MA, Elisaf MS.
    Arch Med Res; 2007 May 16; 38(4):403-10. PubMed ID: 17416287
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.